The molecular mechanism of the anticancer effect of atorvastatin: DNA microarray and bioinformatic analyses

Gao,Yan; Lu,Xue-Chun; Yang,Hong-Ying; Liu,Xian-Feng; Cao,Jian; Fan,Li

doi:10.3892/ijmm.2012.1054

The molecular mechanism of the anticancer effect of atorvastatin: DNA microarray and bioinformatic analyses

Authors:
- Yan Gao
- Xue-Chun Lu
- Hong-Ying Yang
- Xian-Feng Liu
- Jian Cao
- Li Fan
View Affiliations

Affiliations: First Geriatric Cardiology Division, Chinese PLA General Hospital, Beijing 100853, P.R. China, Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, P.R. China, Department of Cardiology, The Fourth People's Hospital of Jinan, Jinan 250032, P.R. China
Published online on: July 4, 2012 https://doi.org/10.3892/ijmm.2012.1054
Pages: 765-774

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to identify the molecular mechanisms and biological pathways associated with the anticancer effects of atorvastatin. For this purpose, we conducted cell-based microarray and bioinformatic analyses to determine the effect of atorvastatin exposure on endothelial cell response. The results of bioinformatic analysis performed using the Connectivity Map (cMap) to examine the atorvastatin-induced changes in gene expression in the human umbilical vein endothelial cell line, EA.hy926, indicated that treatment with 10 µM of atorvastatin for 24 h upregulated the expression of 295 genes and downregulated the expression of 354 genes by 2-fold compared to the control treatment. The gene set enrichment analysis (GSEA), the Database for Annotation, Visualization and Integrated Discovery (DAVID) pathway analysis, and Gene Ontology (GO) analysis of differentially expressed genes revealed that Kruppel-like factors (KLFs) and cell cycle-related genes were the genes most significantly affected by atorvastatin treatment. The upregulation of KLFs and the downregulation of the cell cycle-related genes, including cyclin (CCN)A2, CCNE2, CCNB1 and CCNB2, were validated by real-time polymerase chain reaction (RT-PCR). A comparison of the gene expression profile of atorvastatin-treated cells with that of the control cells and with that of 6,100 compounds in the cMap database revealed that the profile of atorvastatin-treated cells was highly similar to that of histone deacetylase (HDAC) inhibitor-treated cells. Therefore, these results suggest that atorvastatin acts as an HDAC, a G1/S (start) and a G2/M (mitosis) cell cycle inhibitor. These findings provide evidence of the feasibility of the use of atorvastatin as an anticancer drug.

View Figures

View References

1.	C SpampanatoS De MariaM SarnataroSimvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expressionInt J Oncol40935941201222134829
2.	RH SamsonDG NairInfluence and critique of the JUPITER Trial (Statins v no statins for primary prevention of cardiovascular events in patients with normal lipids and elevated C-reactive protein)Semin Vasc Surg24172179201110.1053/j.semvascsurg.2011.10.00522153029
3.	PM RidkerE DanielsonFA FonsecaRosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinN Engl J Med35921952207200810.1056/NEJMoa0807646
4.	AB RosseboTR PedersenK BomanIntensive lipid lowering with simvastatin and ezetimibe in aortic stenosisN Engl J Med35913431356200810.1056/NEJMoa080460218765433
5.	C MarelliC GunnarssonS RossStatins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult AmericansJ Am Coll Cardiol58530537201110.1016/j.jacc.2011.04.01521777752
6.	ZY ChenS RexCC TsengKruppel-like factor 4 is transactivated by butyrate in colon cancer cellsJ Nutr134792798200415051827
7.	MS SimonCA RosenbergRJ RodaboughProspective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer riskAnn Epidemiol221727201210.1016/j.annepidem.2011.10.00622056480
8.	YC YangWF HuangLM ChuanIn vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cellsChemotherapy54438446200810.1159/00015866318824851
9.	K GauthamanCY FongA BongsoStatins, stem cells, and cancerJ Cell Biochem106975983200910.1002/jcb.2209219224538
10.	M UpretiNA KoonceL HenningsTC ChambersRJ GriffinPegylated IFN-alpha sensitizes melanoma cells to chemotherapy and causes premature senescence in endothelial cells by IRF-1 mediated signalingCell Death Dis1e67201010.1038/cddis.2010.4321197417
11.	A SubramanianP TamayoVK MoothaGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesProc Natl Acad Sci USA1021554515550200510.1073/pnas.050658010216199517
12.	National Institute of Allergy and Infectious DiseasesDAVID Bioinformatics Resources 6.7. http://david.abcc.ncifcrf.gov. Accessed January 13, 2012
13.	J LambED CrawfordD PeckThe Connectivity Map: using gene-expression signatures to connect small molecules, genes, and diseaseScience31319291935200610.1126/science.1132939
14.	Broadband InstituteMolecular Signatures Database http://www.broadinstitute.org/gsea/msigdb/indexjsp. Accessed January 13, 2012
15.	Broadband InstituteMap C. www.broadinstitute.org/cmap. Accessed January 13, 2012.
16.	Stanford UniversityIndex of cancer modules. http://robotics.stanford.edu/~erans/cancer/modules. Accessed January 13, 2012
17.	H TaniguchiFV JacintoA VillanuevaSilencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancerOncogene3119881994201210.1038/onc.2011.38721892211
18.	JL YoriDD SeachristE JohnsonKruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancerNeoplasia13601610201121750654
19.	M ZimmerJ LambBL EbertThe connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2Cancer Res7030713079201010.1158/0008-5472.CAN-09-287720354189
20.	YC LinJH LinCW ChouYF ChangSH YehCC ChenStatins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2Cancer Res6823752383200810.1158/0008-5472.CAN-07-580718381445
21.	K PandyaD DonzeTM TownesNovel transactivation domain in erythroid Kruppel-like factor (EKLF)J Biol Chem27682398243200110.1074/jbc.M00845720011092887
22.	AP FunnellCA MaloneyLJ ThompsonErythroid Kruppel-like factor directly activates the basic Kruppel-like factor gene in erythroid cellsMol Cell Biol2727772790200710.1128/MCB.01658-0617283065
23.	B HuangYT AhnL McPhersonC ClaybergerAM KrenskyInteraction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcriptionJ Immunol17870817087200710.4049/jimmunol.178.11.708117513757
24.	E O’GradyH MulcahyC AdamsJP MorrisseyF O’GaraManipulation of host Kruppel-like factor (KLF) function by exotoxins from diverse bacterial pathogensNat Rev Microbiol5337341200717435789
25.	S FischS GrayS HeymansKruppel-like factor 15 is a regulator of cardiomyocyte hypertrophyProc Natl Acad Sci USA10470747079200710.1073/pnas.070198110417438289
26.	AM PilonDG NilsonD ZhouAlterations in expression and chromatin configuration of the alpha hemoglobin-stabilizing protein gene in erythroid Kruppel-like factor-deficient miceMol Cell Biol2643684377200610.1128/MCB.02216-0516705186
27.	SP WangHJ ZhouXP ChenLoss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell linesJ Exp Clin Cancer Res26117124200717550140
28.	S ChanchevalapMO NandanBB McConnellKruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cellsNucleic Acids Res3412161223200610.1093/nar/gkl014
29.	S MukaiT HiyamaS TanakaM YoshiharaK ArihiroK ChayamaInvolvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinomaWorld J Gastroenterol1339323938200710.3748/wjg.v13.i29.393217663506
30.	MC VelardeZ ZengJR McQuownFA SimmenRC SimmenKruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cellsMol Endocrinol2129883001200710.1210/me.2007-0242
31.	ZY ChenX WangY ZhouG OffnerCC TsengDestabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathwayCancer Res651039410400200510.1158/0008-5472.CAN-05-205916288030
32.	XL ZhangD ZhangFJ MichelJL BlumFA SimmenRC SimmenSelective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cellsJ Biol Chem2782147421482200310.1074/jbc.M212098200
33.	JL ShieZY ChenMJ O’BrienRG PestellME LeeCC TsengRole of gut-enriched Kruppel-like factor in colonic cell growth and differentiationAm J Physiol Gastrointest Liver Physiol279G806G814200011005769
34.	AM GhalebBB McConnellMO NandanJP KatzKH KaestnerVW YangHaploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesisCancer Res6771477154200710.1158/0008-5472.CAN-07-130217671182
35.	SL SchoberCT KuoKS SchlunsL LefrancoisJM LeidenSC JamesonExpression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivoJ Immunol16336623667199910490960
36.	M IskarM CampillosM KuhnLJ JensenV van NoortP BorkDrug-induced regulation of target expressionPLoS Comput Biol6e1000925201010.1371/journal.pcbi.1000925
37.	H GuanL XieF LeithauserKLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphomaBlood11614691478201010.1182/blood-2009-12-25644620519630
38.	C BureauN HanounJ TorrisaniJP VinelL BuscailP CordelierExpression and Function of Kruppel Like-Factors (KLF) in CarcinogenesisCurr Genomics10353360200910.2174/13892020978892101020119532
39.	E ChnariJS NikitczukKE UhrichPV MogheNanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDLBiomacromolecules7597603200610.1021/bm050690516471936